Peter Jüni

Peter Jüni is a Swiss physician, general internist, and epidemiologist. He has been the scientific director of the Ontario COVID-19 Science Advisory Table since its formation in July 2020 and works as a director of a research centre at St Michael's Hospital in Toronto.[1]

Peter Jüni
Scientific Director of the Ontario COVID-19 Science Advisory Table
Assumed office
July 2020
Personal details
NationalitySwiss
Alma materBern University
Scientific career
Fields
Institutions

Early life and career

Jüni was born just outside of Bern, Switzerland.[2] He graduated from Bern University and was a Research Fellow at University of Bristol in the Department of Social Medicine before returning to Bern, where he founded the Clinical Trials Unit (CTU) in 2007 and became Director of the Institute of Social and Preventive Medicine in 2013.[2][3]

He moved to Toronto in 2017, where he joined St Michael's Hospital and was appointed professor at the University of Toronto.[2] Jüni is the director of the Applied Health Research Centre (AHRC) at the Li Ka Shing Knowledge Institute and the Canada Research Chair in Clinical Epidemiology of Chronic Diseases.[4][5]

COVID-19

Since July 2020, he has been the scientific director of the Ontario COVID-19 Science Advisory Table (OST) to advise the government during the COVID-19 pandemic in Ontario.[4] He also sits on the OST's Drugs & Biologics Clinical Practice Guidelines Working Group.[6]

Some of his recommendations include better protections and paid sick days for the front-line workers who are disproportionately impacted by the disease.[7] He has at times been critical of the Ontario provincial government's response to the pandemic and has stated that "the government continues to ignore the advice of experts".[7]

In March 2022, Juni announced that he would resign from the Ontario COVID-19 Science Advisory Table and will assume a position at the University of Oxford in July.[1]

Research

Jüni has published over 300 scientific papers in the fields of cardiology and epidemiology, for which he has been recognized as a Highly Cited Researcher by Thomson Reuters.[8] He is an investigator for a study to evaluate favipiravir for potential chemoprophylaxis against COVID-19 in long-term care facilities, sponsored by Appili Therapeutics.[5][9]

References
  1. "Research director to resign from Ontario COVID-19 science table". CityNews Ottawa. The Canadian Press. 2022-03-18. Retrieved 2022-03-20.
  2. Nicholls M (September 2017). "Peter Jüni from Switzerland to Canada". Eur Heart J. 38 (34): 2584–2585. doi:10.1093/eurheartj/ehx442. PMID 28911195.
  3. "Dr. Peter Jüni". Excite International. Archived from the original on 2022-03-18. Retrieved 2022-03-18.
  4. "Peter Jüni | Research at St. Michael's Hospital". Retrieved 2021-04-21.
  5. Jüni, Peter (2021-02-07). "Declaration of Interest" (PDF). Ontario COVID-19 Science Advisory Table. Archived (PDF) from the original on 2022-01-08. Retrieved 2022-03-17.
  6. "About Us". Ontario COVID-19 Science Advisory Table. Retrieved 2022-03-18.
  7. "This doctor almost quit Ontario's COVID-19 scientific advisory table over Ford's response | CBC Radio". Retrieved 2021-04-21.
  8. "Dr. Peter Jüni". Critical Care Canada Forum. Retrieved 2022-03-18.
  9. "Control of Covid-19 outbreaks in long term care". TIBDN: Toronto Invasive Bacterial Diseases Network. Archived from the original on 2021-12-31. Retrieved 2022-03-18.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.